SCHEMBL284187

SCHEMBL284187

C=CCC[C@@H](C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282935 1.00
SCHEMBL282934 1.00
SCHEMBL5868465 0.85 TSHR (0.32)
SCHEMBL2471581 0.83
SCHEMBL22492494 0.83
SCHEMBL6001986 0.83
SCHEMBL13829948 0.81
SCHEMBL570592 0.81
SCHEMBL3815271 0.81
SCHEMBL9540135 0.79 MAPT (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001903-A1 ASCAROSIDE DERIVATIVES AND METHODS OF USE CALIFORNIA INSTITUTE OF TECHNOLOGY 2026-01-01 US disclosed
US-12473323-B2 Ascaroside derivatives and methods of use CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2025-11-18 US disclosed
US-20250032453-A1 20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE NEW YORK MEDICAL COLLEGE 2025-01-30 US disclosed
CN-114423774-B Ascaroside derivatives and methods of use 加利福尼亚技术学院 2024-11-08 CN disclosed
US-20240041831-A1 20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE NEW YORK MEDICAL COLLEGE 2024-02-08 US disclosed
US-11845770-B2 Ascaroside derivatives and methods of use CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-12-19 US disclosed
US-11690825-B2 20-HETE receptor (GPR75) antagonists and methods of use BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-07-04 US disclosed
US-20230135574-A1 ASCAROSIDE DERIVATIVES AND METHODS OF USE HOLOCLARA, INC. 2023-05-04 US disclosed
US-20230135574-A1 ASCAROSIDE DERIVATIVES AND METHODS OF USE HOLOCLARA, INC. 2023-05-04 US disclosed
US-20230135574-A1 ASCAROSIDE DERIVATIVES AND METHODS OF USE HOLOCLARA, INC. 2023-05-04 US disclosed
EP-2219629-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS Abbott Laboratories (US) 2010-08-25 EP disclosed
WO-2010033543-A2 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2010-03-25 WO disclosed
US-20100069348-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2010-03-18 US disclosed
US-20100069349-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2010-03-18 US disclosed
US-20090306310-A1 Method of using click chemistry to functionalize dendrimers THE SCRIPPS RESEARCH INSTITUTE (US) 2009-12-10 US disclosed
US-20090124681-A1 BETA-LACTONE COMPOUNDS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-05-14 US disclosed
US-20090124681-A1 BETA-LACTONE COMPOUNDS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-05-14 US disclosed
US-20090105306-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2009-04-23 US disclosed
WO-2009048936-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2009-04-16 WO disclosed
EP-1985620-A1 10a-AZALIDE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2008-10-29 EP disclosed